Navigation Links
WuXi PharmaTech Announces Second-Quarter 2010 Results
Date:8/1/2010

Services 1,797 795 126% 4,502 1,374 228% Total gross profit 33,207 27,080 23% 63,625 50,399 26% Operating expenses: Selling and marketing expenses (2,333) (2,413) (3%) (4,615) (3,747) 23% General and administrative expenses (14,785) (11,031) 34% (25,485) (22,741) 12% Total operating expenses (17,118) (13,444) 27% (30,100) (26,488) 14% Operating income 16,089 13,636 18% 33,525 23,911 40% Other income (expenses), net: Other income (expenses), net 433 2,975 (85%) 616 6,368 (90%) Interest income (expenses), net 159 144 11% 257 94 173% Total other income (expenses), net 592 3,119 (81%) 873 6,462 (86%) Income before income taxes 16,681 16,755 0% 34,398 30,373 13% Income tax (expenses) benefit (2,923) (2,069) (41%) (5,122) (3,952) 30% Net income 13,758 14,686 (6%) 29,276 26,421 11% Basic net earnings per ADS: 0.20 0.22 (8%) 0.42 0.39 8% Diluted net earnings per ADS: 0.18 0.20 (8%) 0.39 0.36 9% Weighted average ADS outstanding-basic 69,416,476 67,944,436 69,246,669 67,469,104 Weighted average ADS outstanding-diluted 74,591,847 73,152,798 74,465,668 73,356,170 * Not meaningful WUXI PHARMATECH (CAYMAN) INC. RECONCILIATION OF GAAP TO NON-GAAP (in thousands of U.S. dollars, except ADS data and per ADS data) Three Months Ended Six Months Ended June 30, June 30, 2010 2009 % 2010 2009 %
'/>"/>
SOURCE WuXi PharmaTech (Cayman) Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16

Related medicine technology :

1. WuXi PharmaTech RESCHEDULES Second-Quarter 2010 Earnings Conference Call
2. WuXi PharmaTech Well Positioned to Continue Growing as Independent Company; Will Receive Breakup Fee of $30 million
3. WuXi PharmaTech Appoints Hao Zhou as Chief Financial Officer
4. WuXi PharmaTech Announces First-Quarter 2010 Results
5. WuXi PharmaTech Schedules First-Quarter 2010 Earnings Release
6. WuXi PharmaTech Enters into Collaboration with J&JPRD, a division of Janssen Pharmaceutica for Preclinical Services and Training
7. WuXi PharmaTech Passes EMEA Inspection of Its GMP Manufacturing and Analytical Testing Facilities in Shanghai
8. WuXi PharmaTech Schedules Fourth-Quarter 2009 Earnings Release
9. WuXi PharmaTech Included in the Deloitte Technology Fast 500 Asia Pacific 2009 List for the Sixth Consecutive Year
10. Pharmatech, Inc. Contracts for Five New Just-in-Time Clinical Trials
11. Pharmatech Teams up With Systems Medicine LLC and the Sarcoma Foundation of America for a Phase II Myxoid Liposarcoma Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/2/2015)... 2015  Akron Children,s Hospital has been designated a ... College of Radiology (ACR), making it the first hospital ... children,s hospital in the United States ... recognition from the ACR as a DICOE provides validation ... compared with national benchmarks," says Dr. Michael Rubin ...
(Date:3/2/2015)... MENLO PARK, Calif. , March ... (OTCQX: DMPI) (DelMar and the Company), a ... therapies in new orphan drug indications, today announced ... the U.S. Patent and Trademark Office (USPTO) for ... methods to improve the therapeutic benefit of suboptimally ...
(Date:3/2/2015)... , March 2, 2015 /PRNewswire/ - ESSA Pharma ... financial results for the first quarter and three months ... expressed in Canadian dollars and in accordance with International ... ESSA recorded a net loss of ... months ended December 31, 2014 (Q1-2015), compared to a ...
Breaking Medicine Technology:Akron Children's designated ACR Diagnostic Imaging Center of Excellence 2DelMar Pharmaceuticals Receives Notice of Allowance of Fourth U.S. Patent Covering Methods of Use and Compositions for VAL-083 2DelMar Pharmaceuticals Receives Notice of Allowance of Fourth U.S. Patent Covering Methods of Use and Compositions for VAL-083 3DelMar Pharmaceuticals Receives Notice of Allowance of Fourth U.S. Patent Covering Methods of Use and Compositions for VAL-083 4ESSA Pharma Inc. Reports First Quarter 2015 Financial Results 2ESSA Pharma Inc. Reports First Quarter 2015 Financial Results 3ESSA Pharma Inc. Reports First Quarter 2015 Financial Results 4
(Date:3/3/2015)... 03, 2015 AliCare Medical Management ... management programs and a member of the Amalgamated ... Julie O’Brien as President. O’Brien formerly served as ... In her new role, she will continue with ... of AMM’s call center operations, including clinical services, ...
(Date:3/3/2015)... 2015 Aureus Medical Group (web: aureuslocumtenens.com), ... has announced that it will participate as an exhibitor ... March 17, 2015 in St. Louis, MO. , CareerMD ... job-seeking residents and fellows in a comfortable, relaxed setting. ... will be available to speak with attendees about its ...
(Date:3/2/2015)... (PRWEB) March 02, 2015 Calvary ... at their Brooklyn Satellite in Lutheran Medical Center, ... quarterly award must demonstrate excellence through clinical expertise ... also expected to go above and beyond to ... presence with patients and their families. Award recipients ...
(Date:3/2/2015)... Cutler Integrative Medicine a leader in bringing innovative ... tips to bring about self-renewal. A 30 day detox ... first cleaning house. According to Dr. Cutler, expert ... Between environmental toxins like heavy metals, people’s food now ... stress levels, we all have a level of toxic ...
(Date:3/2/2015)... A cocaine snorting Oscar statue ... typical nip slip or scathing scuffle. A new take ... the streets of Hollywood as Paper Jesus’ rendition of ... and substance abuse in Hollywood. The Oscar statue is ... political stance on the travails of drug addiction in ...
Breaking Medicine News(10 mins):Health News:Julie O'Brien Named President of AliCare Medical Management 2Health News:Julie O'Brien Named President of AliCare Medical Management 3Health News:Calvary Hospital Honors Peter Acerios, RN, with Daisy Award 2Health News:Skin and Wellness Power Couple give Quick Tips to Self-Renewal for Spring 2Health News:Oscar Statue Snorting Cocaine Catches All Eyes in Hollywood, Ca 2Health News:Oscar Statue Snorting Cocaine Catches All Eyes in Hollywood, Ca 3
... a radical prostatectomy can be a viable option for ... conventional practice of generally avoiding surgeries for individuals over ... today in Urology. ,“Increased life expectancy and ... forms of anesthesia and less-invasive surgical techniques, have made ...
... and pain killers specified in the First Schedule of ... the// formulations based thereon are under price control and ... Authority (NPPA) in accordance with the provisions of the ... approved/notified price of a Schedule formulation, action is taken ...
... (USDA) today gave the ‘go-ahead’ to market a genetically-engineered ... was in a// mess just 3 months ago regarding ... The approval to market this crop came as a ... shelved any plans of commercialization of the crop. ...
... arrive at a resolution, the emergency planning cell is gearing ... a strike by medical// lab workers. The strike by ... jeopardy, including emergency surgeries. ,Dr Davies said,” Services ... testing of samples such as blood, tissues and swabs for ...
... hormone-free contraceptive pill for men they say would make them ... at King's College London, can be taken hours before sex ... a woman. However, his fertility would return to normal within ... ,Contraceptive pills available in the market now are ...
... Neurofeedback training, developed by NASA aims to help people control ... a new way of ameliorating a wide range of// ailments. ... seizures suffered by astronauts; later this technique was introduced in ... including Kyung Hee University Medical Center adopted this technique, but ...
Cached Medicine News:Health News:Octogenarians Are Not Too Old for Cancer Surgery 2Health News:Tune Your Brain To Fight Disorders 2
Lyphochek Coagulation Control is a human plasma control for monitoring the performance of routine coagulation tests. It has an extended reconstituted stability which helps reduce waste and save money...
Lyphochek Diabetes Control is a human whole blood based product used to monitor hemoglobin fractions associated with diabetes, including Hemoglobins A1, A1C, F and Total Glycated Hemoglobin....
... Urine Toxicology Control is a liquid control ... drug screen panels, including Point of Care ... like Bio-Rad TOX/See, Biosite Triage and other ... (+/) for popular kits and recovery values ...
Lyphochek Hemoglobin A2 Control is a human whole blood based product designed to monitor the performance of automated and manual procedures for the measurement of hemoglobin variants, including Hemog...
Medicine Products: